NO20072387L - Pseudotypet Baculovirus og anvendelse derav - Google Patents

Pseudotypet Baculovirus og anvendelse derav

Info

Publication number
NO20072387L
NO20072387L NO20072387A NO20072387A NO20072387L NO 20072387 L NO20072387 L NO 20072387L NO 20072387 A NO20072387 A NO 20072387A NO 20072387 A NO20072387 A NO 20072387A NO 20072387 L NO20072387 L NO 20072387L
Authority
NO
Norway
Prior art keywords
baculovirus
pseudotyped
pseudotyped baculovirus
protein
domains
Prior art date
Application number
NO20072387A
Other languages
English (en)
Inventor
Seppo Yla-Herttuala
Kari Juhani Airenne
Minna U Kaikkonen
Jani K Raty
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Publication of NO20072387L publication Critical patent/NO20072387L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
    • C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Viralt G protein-pseudotypet baculovirus, hvor G proteinet er forkortet og omfatter ektodomene, transmembrandomene og cytoplasmatisk haledomene. Slikt baculovirus kan anvendes for transduksjon av celler og for genterapi.
NO20072387A 2004-11-03 2007-05-09 Pseudotypet Baculovirus og anvendelse derav NO20072387L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424357A GB0424357D0 (en) 2004-11-03 2004-11-03 Pseudotyped baculovirus
PCT/GB2005/004263 WO2006048662A1 (en) 2004-11-03 2005-11-03 Pseudotyped baculovirus and its use

Publications (1)

Publication Number Publication Date
NO20072387L true NO20072387L (no) 2007-05-31

Family

ID=33523148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072387A NO20072387L (no) 2004-11-03 2007-05-09 Pseudotypet Baculovirus og anvendelse derav

Country Status (9)

Country Link
US (1) US20080280363A1 (no)
EP (1) EP1807444A1 (no)
AU (1) AU2005300345A1 (no)
CA (1) CA2585886A1 (no)
GB (1) GB0424357D0 (no)
IL (1) IL182877A0 (no)
NO (1) NO20072387L (no)
WO (1) WO2006048662A1 (no)
ZA (1) ZA200703575B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2542678B1 (en) 2010-03-04 2017-04-12 InteRNA Technologies B.V. A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS THERAPEUTIC USES IN CANCER ASSOCIATED WITH EMT
EP2591106A1 (en) 2010-07-06 2013-05-15 InteRNA Technologies B.V. Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
EP3369818B1 (en) 2011-12-22 2021-06-09 InteRNA Technologies B.V. Mirna for treating head and neck cancer
EP2917348A1 (en) 2012-11-06 2015-09-16 InteRNA Technologies B.V. Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway
CN111566212A (zh) 2017-11-03 2020-08-21 因特尔纳技术有限公司 miRNA分子，等同物，安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease

Also Published As

Publication number Publication date
AU2005300345A1 (en) 2006-05-11
GB0424357D0 (en) 2004-12-08
IL182877A0 (en) 2007-08-19
ZA200703575B (en) 2008-09-25
EP1807444A1 (en) 2007-07-18
US20080280363A1 (en) 2008-11-13
CA2585886A1 (en) 2006-05-11
WO2006048662A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
NO20072387L (no) Pseudotypet Baculovirus og anvendelse derav
NO20075992L (no) Forbindelser som modulerer C-Kit og C-FMS aktivitet og anvendelser derav
MX2009005428A (es) Compuestos que modulan actividad c-fms y/o c-kit y usos para ello.
DK1701946T3 (da) 1-piperazin- og 1-homopiperazincarboxylatderivater, deres fremstilling og deres terapeutiske anvendelse som inhibitorer af FAAH-enzymet
ATE525098T1 (de) Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers
NO20043259L (no) Bindingsproteiner som biosensorer
ATE402663T1 (de) Flächiges implantat
WO2007127464A3 (en) Methods and compounds to modulate parvovirus transduction of mammalian cells or to alter virus infection, method to identify a viral receptor or co-receptor
NO20074654L (no) Lenteviral-vektorer og deres anvendelse
BR0313033A (pt) anticorpos, anticorpos monoclonais, linhagens de células de hibridoma, anticorpos receptores de anti-taci isolados, anticorpos anti -taci, métodos de modulação da atividade biológica
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
ZA200606620B (en) Methods of modulating IL-23 activity ; related reagents
WO2006099405A3 (en) Bandage with splint
IS7638A (is) Asabísýkló-oktan- og nónanafleiður með DDP-IV tálmunarvirkni
BRPI0409701A (pt) ligantes de receptores de canabinóides e seus usos
EA202092589A2 (ru) Cxcr2-связывающие полипептиды
PT1257648E (pt) Agentes antagonísticos de ligação selectiva da proteína de ligação da osteoprotegerina
AR051942A1 (es) Anticuerpos anti-virus respiratorio sincitial, antigenos y usos de los mismos
EP4164651C0 (en) 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR USE IN THE TREATMENT OF CORONAVIRAL INFECTIONS
WO2008154456A3 (en) Methods and compositions relating to viral fusion proteins
WO2007089336A3 (en) Certain chemical entities, compositions and methods
ATE472334T1 (de) Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind
MX2007008136A (es) Metodo para invertir la resistencia multiple en celulas animales.
DK1499729T3 (da) Derivater af det NF-kappab-inducerende enzym, fremstilling og anvendelse deraf
EP1976548A4 (en) VIP FRAGMENTS AND APPLICATION PROCEDURES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application